Galnt1 is required for normal heart valve development and cardiac function

PLoS ONE

Volumn 10, Issue 1, 2015, Pages

  Tian, E ^a   Stevens, Sharon R ^a   Guan, Yu ^a   Springer, Danielle A ^b   Anderson, Stasia A ^b   Starost, Matthew F ^b   Patel, Vyomesh ^a,c   Hagen, Kelly G Ten ^a   Tabak, Lawrence A ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c CANCER RESEARCH INITIATIVES FOUNDATION   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMTS1 PROTEIN; AGGRECANASE 2; BONE MORPHOGENETIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SCLEROPROTEIN; VERSICAN; ADAM PROTEIN; ADAMTS1 PROTEIN, MOUSE; ADAMTS5 PROTEIN, MOUSE; N ACETYLGALACTOSAMINYLTRANSFERASE; POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; FEMALE; GALNT1 GENE; GENE; GLYCOSYLATION; HEART DEVELOPMENT; HEART EJECTION FRACTION; HEART FUNCTION; HEART VALVE; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN MODIFICATION; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE STENOSIS; SIGNAL TRANSDUCTION; ANIMAL; CONGENITAL HEART MALFORMATION; DISEASE MODEL; GENETICS; HUMAN; MAMMALIAN EMBRYO; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA;

ADAM PROTEINS; ADAMTS1 PROTEIN; ADAMTS5 PROTEIN; ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; EXTRACELLULAR MATRIX PROTEINS; HEART DEFECTS, CONGENITAL; HEART VALVES; HUMANS; MAP KINASE SIGNALING SYSTEM; MICE; N-ACETYLGALACTOSAMINYLTRANSFERASES;

EID: 84921811334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0115861     Document Type: Article

References (32)

1. Hinton RB, Yutzey KE (2011) Heart valve structure and function in development and disease. Annu Rev Physiol 73: 29-46. doi: 10.1146/annurev-physiol-012110-142145 PMID: 20809794
2. Barrick CJ, Roberts RB, Rojas M, Rajamannan NM, Suitt CB, et al. (2009) Reduced EGFR causes abnormal valvular differentiation leading to calcific aortic stenosis and left ventricular hypertrophy in C57BL/6J but not 129S1/SvImJ mice. Am J Physiol Heart Circ Physiol 297: H65-75. doi: 10.1152/ ajpheart.00866.2008 PMID: 19448146
3. Kruithof BP, Duim SN, Moerkamp AT, Goumans MJ (2012) TGFbeta and BMP signaling in cardiac cushion formation: lessons from mice and chicken. Differentiation 84: 89-102. doi: 10.1016/j.diff.2012. 04.003 PMID: 22656450
4. DeLaughter DM, Christodoulou DC, Robinson JY, Seidman CE, Baldwin HS, et al. (2013) Spatial transcriptional profile of the chick and mouse endocardial cushions identify novel regulators of endocardial EMT in vitro. J Mol Cell Cardiol 59: 196-204. doi: 10.1016/j.yjmcc.2013.03.016 PMID: 23557753
5. Lim J, Thiery JP (2012) Epithelial-mesenchymal transitions: insights from development. Development 139: 3471-3486. doi: 10.1242/dev.071209 PMID: 22949611
6. Lockhart M, Wirrig E, Phelps A, Wessels A (2011) Extracellular matrix and heart development. Birth Defects Res A Clin Mol Teratol 91: 535-550. doi: 10.1002/bdra.20810 PMID: 21618406
7. Combs MD, Yutzey KE (2009) Heart valve development: regulatory networks in development and disease. Circ Res 105: 408-421. doi: 10.1161/CIRCRESAHA.109.201566 PMID: 19713546
8. Tian E, Hoffman MP, Ten Hagen KG (2012) O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components. Nat Commun 3: 869. doi: 10.1038/ ncomms1874 PMID: 22643896
9. Bennett EP, Mandel U, Clausen H, Gerken TA, Fritz TA, et al. (2012) Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22: 736-756. doi: 10.1093/glycob/cwr182 PMID: 22183981
10. Tenno M, Ohtsubo K, Hagen FK, Ditto D, Zarbock A, et al. (2007) Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol Cell Biol 27: 8783-8796. doi: 10.1128/MCB.01204-07 PMID: 17923703
11. Savolainen SM, Foley JF, Elmore SA (2009) Histology atlas of the developing mouse heart with emphasis on E11.5 to E18.5. Toxicol Pathol 37: 395-414. doi: 10.1177/0192623309335060 PMID: 19359541
12. Rose BA, Force T, Wang Y (2010) Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale. Physiol Rev 90: 1507-1546. doi: 10.1152/physrev.00054.2009 PMID: 20959622
13. Jackson LF, Qiu TH, Sunnarborg SW, Chang A, Zhang C, et al. (2003) Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J 22: 2704-2716. doi: 10.1093/emboj/cdg264 PMID: 12773386
14. Afrakhte M, Morén A, Jossan S, Itoh S, Sampath K, et al. (1998) Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem Biophys Res Commun 249: 505-511. doi: 10.1006/bbrc.1998.9170 PMID: 9712726
15. Kern CB, Twal WO, Mjaatvedt CH, Fairey SE, Toole BP, et al. (2006) Proteolytic cleavage of versican during cardiac cushion morphogenesis. Dev Dyn 235: 2238-2247. doi: 10.1002/dvdy.20838 PMID: 16691565
16. Dupuis LE, McCulloch DR, McGarity JD, Bahan A, Wessels A, et al. (2011) Altered versican cleavage in ADAMTS5 deficient mice; a novel etiology of myxomatous valve disease. Dev Biol 357: 152-164. doi: 10.1016/j.ydbio.2011.06.041 PMID: 21749862
17. Kern CB, Wessels A, McGarity J, Dixon LJ, Alston E, et al. (2010) Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies. Matrix Biol 29: 304-316. doi: 10.1016/j.matbio.2010.01.005 PMID: 20096780
18. Russell DL, Doyle KMH, Ochsner SA, Sandy JD, Richards JS (2003) Processing and Localization of ADAMTS-1 and Proteolytic Cleavage of Versican during Cumulus Matrix Expansion and Ovulation. J Biol Chem 278:42330-42339.
19. Liu YJ, Xu Y, Yu Q (2006) Full-length ADAMTS-1 and the ADAMTS-1 fragments display pro- and antimetastatic activity respectively. Oncogene 25:2452-2467. doi: 10.1038/sj.onc.1209287 PMID: 16314835
20. Freitas VM, do Amaral JB, Silva TA, Santos ES, Mangone FR, et al. (2013) Decreased expression of ADAMTS-1 in human breast tumors stimulates migration and invasion. Mol cancer 12:2-15. doi: 10.1186/1476-4598-12-2 PMID: 23289900
21. Kumar S, Sharghi-Namini S, Rao N, Ge R (2012) ADAMTS5 functions as an anti-angiogenic and antitumorigenic protein independent of its proteoglycanase activity. Am J Pathol 181: 1056-1068. doi: 10.1016/j.ajpath.2012.05.022 PMID: 22796434
22. Llamazares M, Cal S, Quesada V, López-Otín C (2003) Identification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domain. J Biol Chem 278: 13382-13389. doi: 10.1074/jbc.M211900200 PMID: 12562771
23. Foulcer SJ, Nelson CM, Quintero MV, Kuberan B, Larkin J, et al. (2014) Determinants of Versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5. J Biol Chem 289: 27859-27873. doi: 10.1074/jbc.M114.573287 PMID: 25122765
24. Wirrig EE, Snarr BS, Chintalapudi MR, O'Neal JL, Phelps AL, et al. (2007) Cartilage link protein 1 (Crtl1), an extracellular matrix component playing an important role in heart development. Dev Biol 310: 291-303. doi: 10.1016/j.ydbio.2007.07.041 PMID: 17822691
25. Armstrong EJ, Bischoff J (2004) Heart valve development: endothelial cell signaling and differentiation. Circ Res 95: 459-470. doi: 10.1161/01.RES.0000141146.95728.da PMID: 15345668
26. Schroeder JA, Jackson LF, Lee DC, Camenisch TD (2003) Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. J Mol Med 81: 392-403. doi: 10.1007/s00109-003-0456-5 PMID: 12827270
27. Kretzschmar M, Liu F, Hata A, Doody J, Massague J (1997) The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11: 984-995. doi: 10.1101/gad.11.8.984 PMID: 9136927
28. Krenz M, Gulick J, Osinska HE, Colbert MC, Molkentin JD, et al. (2008) Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome. Proc Natl Acad Sci U S A 105: 18930-18935. doi: 10.1073/pnas.0806556105 PMID: 19017799
29. Wight TN (2002) Versican: a versatile extracellular matrix proteoglycan in cell biology. Curr Opin Cell Biol 14: 617-623. doi: 10.1016/S0955-0674(02)00375-7 PMID: 12231358
30. Hatano S, Kimata K, Hiraiwa N, Kusakabe M, Isogai Z, et al. (2012) Versican/PG-M is essential for ventricular septal formation subsequent to cardiac atrioventricular cushion development. Glycobiology 22: 1268-1277. doi: 10.1093/glycob/cws095 PMID: 22692047
31. Garbern JC, Lee RT (2013) Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12: 689-698. doi: 10.1016/j.stem.2013.05.008 PMID: 23746978
32. Radisic M, Christman KL (2013) Materials science and tissue engineering: repairing the heart. Mayo Clin Proc 88: 884-898. doi: 10.1016/j.mayocp.2013.05.003 PMID: 23910415